Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
This study is currently recruiting participants.
Study NCT00623831 Information provided by Ludwig Institute for Cancer Research
First Received: February 4, 2008 Last Updated: September 23, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Melanoma
Sarcoma
Head and Neck Cancer
Transitional Cell Carcinoma
Prostate Cancer
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Transitional Cell
Gastrointestinal Stromal Tumors
Head and Neck Neoplasms
Prostatic Neoplasms
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
Mixed Bacterial Vaccine (MBV)
Sponsors listed in this trial
Ludwig Institute for Cancer Research
Back to top of Main Content
